Clinical Trials Directory

Trials / Completed

CompletedNCT05449171

High Molecular Weight Hyaluronic Acid, α-lipoic Acid, Magnesium, Vitamin B6 and Vitamin D, in the Prevention of Spontaneous Abortion

Efficacy of the Association of Hyaluronic Acid With High Molecular Weight, α-lipoic Acid (ALA), Magnesium, Vitamin B6 and Vitamin D, in the Prevention of Spontaneous Abortion in Patients at Risk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Lo.Li.Pharma s.r.l · Industry
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The study aims to verify if the association of high molecular weight hyaluronic acid, α-lipoic acid (ALA), magnesium, vitamin B6 and vitamin D, reduces the risk of miscarriage in patients at risk.

Conditions

Interventions

TypeNameDescription
OTHERhigh molecular weight hyaluronic acid, α-lipoic acid (ALA), magnesium, vitamin B6 and vitamin DPatients will take an association of high molecular weight hyaluronic acid, α-lipoic acid (ALA), magnesium, vitamin B6 and vitamin D, from the first visit at the experimental center (within the 12th week of gestation) for 3 months.

Timeline

Start date
2022-09-01
Primary completion
2023-09-01
Completion
2024-01-31
First posted
2022-07-08
Last updated
2024-02-22

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05449171. Inclusion in this directory is not an endorsement.